Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 62,802 |
| Other current assets | 0 | 0 | 0 | 1,529 |
| TOTAL | $0 | $0 | $0 | $64,331 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 11,330 |
| Other Non-Current Assets | 0 | 0 | 0 | 214 |
| TOTAL | $N/A | $N/A | $N/A | $11,544 |
| Total Assets | $0 | $0 | $0 | $72,682 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,806 |
| Accrued Expenses | 0 | 0 | 0 | 1,573 |
| Other current liabilities | 0 | 0 | 0 | 5,824 |
| TOTAL | $0 | $0 | $0 | $9,203 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,252 |
| TOTAL | $N/A | $N/A | $N/A | $89,848 |
| Total Liabilities | $0 | $0 | $0 | $99,051 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -39,111 |
| Other shareholders' equity | 0 | 0 | 0 | 51 |
| TOTAL | $0 | $0 | $0 | $-26,369 |
| Total Liabilities And Equity | $0 | $0 | $0 | $72,682 |